Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Yuki Gosei Kogyo Co., Ltd.. A complete text table follows the diagram.
Chemical products led the mix, while pharmaceutical exports drove growth across a three-part product portfolio.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Amino-acid products | 1 | 2.4B | 31.1% of reported total |
| Chemical products | 1 | 3.0B | 38.1% of reported total |
| Pharmaceutical products | 1 | 2.4B | 30.7% of reported total |
| Rounding residual | 1 | 2M | 0.0% of reported total |
| Gross specialty chemical and pharmaceutical products | 2 | 7.8B | Reported six-month total · ¥7.8B |
| Specialty chemical and pharmaceutical products | 3 | 7.8B | Reported consolidated total |
| Eliminations & reconciliation | 3 | 2M | Reported dimensional reconciliation |
| Operating profit | 4 | 262M | 3.4% operating margin |
| Operating costs & expenses | 4 | 7.6B | Arithmetic residual to reported operating profit |
| Profit before tax | 5 | 198M | Reported pretax result |
| Exports turned specialty chemistry into growth | 5 | 64M | Pharmaceutical exports and polymer materials helped lift sales to ¥7.82bn, with exports reaching 58.4% of revenue. |
| Net profit attributable to owners | 6 | 165M | Reported parent-company result |
| Tax, attribution & other | 6 | 33M | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Amino-acid products | Gross specialty chemical and pharmaceutical products | 2.4B |
| Chemical products | Gross specialty chemical and pharmaceutical products | 3.0B |
| Pharmaceutical products | Gross specialty chemical and pharmaceutical products | 2.4B |
| Rounding residual | Gross specialty chemical and pharmaceutical products | 2M |
| Gross specialty chemical and pharmaceutical products | Specialty chemical and pharmaceutical products | 7.8B |
| Gross specialty chemical and pharmaceutical products | Eliminations & reconciliation | 2M |
| Specialty chemical and pharmaceutical products | Operating profit | 262M |
| Specialty chemical and pharmaceutical products | Operating costs & expenses | 7.6B |
| Operating profit | Profit before tax | 198M |
| Operating profit | Exports turned specialty chemistry into growth | 64M |
| Profit before tax | Net profit attributable to owners | 165M |
| Profit before tax | Tax, attribution & other | 33M |